Caries-Preventive Effect and Retention of Glass-Ionomer and Resin-Based Sealants: A Randomized Clinical Comparative Evaluation

Table 2

Baseline, 6-month, 12-month, and 18-month clinical control values.

(a)

		Grandioseal	Smartseal	Fuji triage	value
Retention loss
Baseline	Successful	50 (100%)	50 (100%)	50 (100%)	1.00
	Acceptable	-	-	-
	Unsuccessful	-	-	-
6-month	Successful	41 (95.3%)	37 (86.0%)	38 (88.4%)	0.476
	Acceptable	0 (.0%)	3 (7.0%)	3 (7.0%)
	Unsuccessful	2 (4.7%)	3 (7.0%)	2 (4.6%)
12-month	Successful	25 (65.8%)	13 (34.2%)	16 (42.1%)	0.052
	Acceptable	8 (21.1%)	11 (29%)	9 (23.7%)
	Unsuccessful	5 (13.1%)	14 (36.8%)	13 (34.2%)
18-month	Successful	17 (51.6%)	8 (24.2%)	6 (18.2%)	0.046
	Acceptable	8 (24.2%)	12 (36.4%)	13 (33.3%)
	Unsuccessful	8 (24.2%)	13 (39.4%)	14 (42.5%)
Marginal adaptation
Baseline	Sound	50 (100%)	50 (100%)	50 (100%)	1.00
	Acceptable	-	-	-
	Missing	-	-	-
6-month	Sound	41 (95.3%)	36 (83.7)	41 (95.3%)	0.069
	Acceptable	0 (.0%)	4 (9.3%)	0 (.0)
	Missing	2 (4.7%)	3 (7.0%)	2 (4.7%)
12-month	Sound	29 (76.3%)	15 (39.5%)	21 (55.3%)	0.013
	Acceptable	4 (10.5%)	10 (26.3%)	4 (10.5%)
	Missing	5 (13.2%)	13 (34.2%)	13 (34.2%)
18-month	Sound	21 (63.7%)	11 (33.3%)	14 (42.4%)	0.110
	Acceptable	4 (12.1%)	9 (27.3%)	5 (15.2%)
	Missing	8 (24.2%)	13 (39.4%)	14 (42.4%)
Surface roughness
Baseline	Successful	50 (100%)	50 (100%)	50 (100%)	1.00
	Acceptable	-	-	-
	Unsuccessful	-	-	-
6-month	Successful	41 (95.3%)	36 (83.7%)	41 (95.3%)	0.069
	Acceptable	0 (.0%)	4 (9.3%)	0 (.0%)
	Unsuccessful	2 (4.7%)	3 (7.0%)	2 (4.7%)
12-month	Successful	29 (76.3%)	15 (39.5%)	22 (57.9%)	0.004
	Acceptable	4 (10.5%)	10 (26.3%)	2 (5.3%)
	Unsuccessful	5 (13.2%)	13 (43.2%)	14 (36.8%)
18-month	Successful	18 (54.5%)	12 (36.4%)	16 (48.5%)	0.256
	Acceptable	7 (21.3%)	8 (24.2%)	3 (9.1%)
	Unsuccessful	8 (24.2%)	13 (39.4%)	14 (42.4%)
Visual evaluation
Baseline	Successful	50 (100%)	50 (100%)	50 (100%)	1.00
	Acceptable	-	-	-
	Unsuccessful	-	-	-
6-month	Successful	41 (95.3%)	38 (88.4%)	41 (95.3%)	0.350
	Acceptable	0 (.0%)	2 (4.6%)	0 (.0)
	Unsuccessful	2 (4.7%)	3 (7.0%)	2 (4.7%)
12-month	Successful	32 (83.8%)	16 (42.1%)	22 (57.9%)	0.001
	Acceptable	1 (2.7%)	9 (23.7%)	2 (5.3%)
	Unsuccessful	5 (13.5%)	13 (34.2%)	14 (36.8%)
18-month	Successful	24 (72%)	11 (33.3%)	15 (45.5%)	0.044
	Acceptable	1 (3.0%)	9 (27.3%)	4 (12.1%)
	Unsuccessful	8 (24%)	13 (39.4%)	14 (42.4%)

(b)

		Control	Grandioseal	Smartseal	Fuji triage	value
Marginal coloration
Baseline	Successful	47 (94.0%)	50 (100%)	48 (96.0%)	49 (98.0%)	0.33
	Acceptable	3 (6.0%)	0 (.0%)	1 (2.0%)	1 (2.0%)
	Unsuccessful	0 (.0%)	0 (.0%)	1 (.2.0%)	0 (.0%)
6-month	Successful	40 (93.0%)	43 (100.0%)	42 (97.7%)	42 (97.7%)	0.27
	Acceptable	3 (7.0%)	0 (.0%)	1 (2.3%)	1 (2.3%)
	Unsuccessful	-	-	-	-
12-month	Successful	31 (81.6%)	32 (84.2%)	29 (76.3%)	28 (73.7%)	0.31
	Acceptable	5 (13.2%)	3 (7.9%)	5 (13.2%)	2 (5.3%)
	Unsuccessful	2 (5.3%)	3 (7.9%)	4 (10.5%)	8 (21.2%)
18-month	Successful	24 (72.7%)	24 (72.7%)	22 (66.7%)	22 (66.7%)	0.79
	Acceptable	6 (18.2%)	5 (15.2%)	7 (21.2%)	4 (12.1%)
	Unsuccessful	3 (9.1%)	4 (12.1%)	4 (12.1%)	7 (21.2%)
Caries status
Baseline	No caries	50 (100%)	50 (100%)	50 (100%)	50 (100%)
	Caries	-	-	-	-
6-month	No caries	40 (93%)	41 (95.3%)	42 (97.7%)	42 (97.7%)	0.65
	Caries	3 (7.0)	2 (4.7%)	1 (2.3%)	1 (2.3%)
12-month	No caries	34 (89.50%)	36 (94.7%)	37 (97.4%)	1 (97.3)	0.37
	Caries	4 (10.5%)	2 (5.3%)	1 (2.6%)	1 (2.7%)
18-month	No caries	26 (74.3%)	29 (90.6%)	32 (97.0%)	32 (97.0%)	0.37
	Caries	9 (25.7%)	3 (9.4%)	1 (3.0%)	1 (3.0%)